Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Preoperative pain assessment, regional anesthesia, and vitamin C can help prevent CRPS after surgery.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Minoxidil and finasteride effectively treat hair loss.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

No cure for female pattern hair loss, but various effective treatments exist.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Nearly all elderly nursing home residents had a skin disease, with dry skin being the most common.

Mothers and newborns with dental fillings had higher mercury in their hair, but getting fillings during pregnancy didn't raise mercury levels further.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Menopause affects hair and skin; more research needed for treatment.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.